EE60 An Economic Evaluation of Introducing Ferric Carboxymaltose for the Treatment of Iron Deficiency in Patients With Heart Failure From the Perspective of Healthcare Payers in Sweden, Germany, France, Poland and Spain
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.312
https://www.valueinhealthjournal.com/article/S1098-3015(22)02516-5/fulltext
Title :
EE60 An Economic Evaluation of Introducing Ferric Carboxymaltose for the Treatment of Iron Deficiency in Patients With Heart Failure From the Perspective of Healthcare Payers in Sweden, Germany, France, Poland and Spain
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02516-5&doi=10.1016/j.jval.2022.09.312
First page :
Section Title :
Open access? :
No
Section Order :
12118